2023 AGENDA
7:30 - 8:25 AM
Check-in & Networking Breakfast
8:25 - 8:35 AM
Opening & Hot Topics in the Retina Space
Presented By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group
8:35 - 9:55AM
Innovation Showcase
Outlook Therapeutics | Russell Trenary, President & CEO
Ophthorobotics | Bernhard Guenther, CEO & Chairman of the Board
Ocuphire Pharma | Ronil Patel, MS, SVP, Operations & Business Development
Oculis | Riad Sherif, Director & CEO
Twenty/Twenty Therapeutics | Alexandre R. Tumlinson, Product Lead
Coherus Biosciences | Denny M. Lanfear, Chairman & CEO
Opthea Limited | Megan Baldwin, PhD, CEO & Managing Director
Valitor | Wesley Jackson, PhD, Co-Founder & CSO
RetinAI | Carlos Ciller, PhD, Co-Founder & CEO
LumiThera | Clark Tedford, PhD, President & CEO
Stealth BioTherapeutics | Reenie McCarthy, CEO
Regeneron | Kevin Clark, Vice President, Ophthalmology
9:55 - 10:15 AM
Fireside Chat
Perspectives on Ray Therapeutics' Successful $100 Million Series A
Participant:
Paul Bresge, CEO - Ray Therapeutics
Interviewed By:
Pravin U. Dugel, MD, President - Iveric Bio
10:15 - 10:45 AM
Morning Networking & Refreshment Break
10:45 - 11:45 AM
Spotlight on Drug Delivery
Introduction/Overview
Presented By:
Thomas Ciulla, MD, MBA, Clinical Professor of Ophthalmology, Volunteer - Indiana University School of Medicine / Vitreoretinal Medicine and Surgery - Midwest Eye Institute
Ocular Therapeutix | Peter Kaiser, MD, Chief Medical Advisor, Retina
EyePoint Pharmaceuticals | Nancy Lurker, Executive Vice-Chair, Board of Directors
Clearside Biomedical | George Lasezkay, PharmD, President & CEO
Re-Vana Therapeutics | Michael O'Rourke, CEO
Expert Panel Discussion
Panelists:
Caroline Baumal, MD, Professor of Ophthalmology - Tufts Medical Center / Chief Medical Officer - Apellis Pharmaceuticals
Robert Avery, MD, Founder & CEO - California Retina Consultants
Baruch Kuppermann, MD, PhD, Steinert Professor and Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute - University of California
Carlos Quezada Ruiz, MD, Vitreoretinal Surgeon, Retina Consultant & Group Medical Director, Clinical Science - Genentech
Moderated By:
María H. Berrocal, MD, Director - Berrocal & Associates
11:45 - 12:50 PM
Spotlight on Regenerative Medicine
KOL Introduction
Presented By:
John S. Pollack, MD, Illinois Retina Associates
Ray Therapeutics | Peter Francis, MD, Chief Medical & Scientific Officer
jCyte | Adrian Morris, Chief Development Officer
REGENXBIO | Stephen Pakola, MD, Chief Medical Officer
SparingVision | Daniel Chung, DO, Chief Medical Officer
Expert Panel Discussion
Panelists:
Daniel Chung, DO, Chief Medical Officer - SparingVision
Peter Francis, MD, Chief Medical & Scientific Officer - Ray Therapeutics
Sun Young Lee, MD, PhD, Assistant Professor - USC Roski Eye Institute
Adrian Morris, Chief Development Officer - jCyte
Ram Palanki, PharmD, Executive Vice President, Commercial Strategy & Operations - REGENXBIO
Moderated By:
Mark S. Humayun, MD, PhD, Professor of Ophthalmology and Director - University of Southern California Roski Eye Institute
12:50 - 1: 35
Networking Lunch
1:35 - 2:45 PM
Spotlight on Dry AMD
Overview
Presented By:
Andrew Moshfeghi, MD, MBA, Associate Professor of Clinical Ophthalmology, Director of Clinical Trials, & Director of the Medical Retina and Surgical Retina Fellowship Programs - University of Southern California
Iveric Bio | Dhaval Desai, SVP & Chief Development Officer
Apellis Pharmaceuticals | Cedric Francois, MD, PhD, Co-Founder & CEO
Aviceda Therapeutics | Tarek Hassan, MD, Chief Development Officer & Senior Vice President
Galimedix Therapeutics | Hermann Russ, MD, PhD, Chief Scientific Officer & Co-Founder
Lineage Cell Therapeutics | Gary S. Hogge, DVM, MS, PhD, SVP, Clinical & Medical Affairs
Expert Panel Discussion
Panelists:
Jennifer I. Lim, MD, Marion H. Schenk Esq. Chair, Distinguished Professor of Ophthalmology
Director of Retina Service &Vice-Chair for Diversity and Inclusion - University of Illinois at Chicago
Andrew Moshfeghi, MD, MBA, Associate Professor of Clinical Ophthalmology, Director of Clinical Trials, & Director of the Medical Retina and Surgical Retina Fellowship Programs - University of Southern California
Nadia Waheed, MD, Professor - Tufts University School of Medicine
Moderated By:
Peter Kaiser, MD, Professor of Ophthalmology - Cleveland Clinic
2:45 - 3:25 PM
Utilization of AI
What is AI? Is it Ready for Application in Retina?
Panelists:
Justis Ehlers, MD, The Norman C. and Donna L. Harbert Endowed Chair of Ophthalmic Research - Cole Eye Institute at Cleveland Clinic
Ursula Schmidt-Erfurth, MD, Professor and Chair of the Department of Ophthalmology - the University Eye Hospital, Vienna, Austria
Daniela Ferrara, MD, PhD, Principal Medical Director, Genentech / Assistant Professor of Ophthalmology, Tufts University
SriniVas R. Sadda, MD, Director, Artificial Intelligence & Imaging Research, Doheny Eye Institute / Professor of Ophthalmology- UCLA - David Geffen School of Medicine
Omer Trivizki, MD, MBA, Vice Chair, Ophthalmology, Tel-Aviv Medical Center; Digital Initiative Leader, Tel Aviv Medical Center
Lejla Vajzovic, MD, Associate Professor of Ophthalmology - Duke University School of Medicine
Moderated By:
Anat Loewenstein, MD, Head, Department of Ophthalmology - Tel Aviv Medical Center / Vice-Dean of Medical School, Tel Aviv University
3:25 - 3:50 PM
Afternoon Networking & Refreshment Break
3:50 - 4:20 PM
Early-stage Relationships Between Venture Investors & Startup CEOs
Panelists:
Group 1
Firas M. Rahhal, MD, Partner - ExSight Ventures
David Esposito, CEO - ONL Therapeutics
Group 2
Lori-Ann Christie, PhD, Principal - Visionary Venture Fund
Michael O’Rourke, CEO – Re-Vana Therapeutics
Moderated By:
James Murray, Co-Founder & Partner - ExSight Ventures
4:20 - 4:50 PM
The View From The Street
Panelists:
Cariad Chester, Partner - TCG Crossover
Anupam Dalal, MD, Chief Investment Officer and Managing Member - Acuta Capital Partners
Jason Jun, Managing Director, Healthcare Investment Banking - Citi
Cameron Taylor, Managing Director - BofA Securities | Life Sciences
Moderated By:
Pravin U. Dugel, MD, President - Iveric Bio
4:50 - 5:20 PM
Reverse Pitch by Strategics
Panelists:
Paul Hallen, Vice President & Global Head, Retina - Alcon
Céline Olmiere, PhD, Chief Scientific Officer - Théa Open Innovation
Anthony Wallace, Vice President & General Manager - Bausch + Lomb
Moderated By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group
5:20 - 5:35 PM
Retina Innovator Award Presentation
Cedric Francois, CEO - Apellis Pharmaceuticals
Interviewed by:
María H. Berrocal, MD, Director - Berrocal & Associates
5:35 - 6:35 PM